NUCLEIC ACID INSIGHTS

Next-level LNP formulation with the Sunny Suite

Next-level LNP formulation with the Sunny Suite

Benjamin Knappett
26 March 2025
Watch
Key considerations for successful clinical development of mRNA therapeutics

Key considerations for successful clinical development of mRNA therapeutics

26 March 2025
Infographic
Sharpen up your RNA and LNP quant with Stunner

Sharpen up your RNA and LNP quant with Stunner

Kevin Lance
19 March 2025
Watch
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

Stanley Crooke
12 March 2025
Interview
Solving unique analytical challenges in mRNA-LNP bioprocessing with precise measurement methods

Solving unique analytical challenges in mRNA-LNP bioprocessing with precise measurement methods

Nigel Herbert
11 March 2025
Watch
Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

Ketaki Deshmukh
19 February 2025
Podcast
Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

09 December 2024
Conference Insight
Improving lipid nanoparticle formulations for targeted delivery of genome editors

Improving lipid nanoparticle formulations for targeted delivery of genome editors

Rohit Sharma
05 November 2024
Interview
Potential use of lipid nanoparticles in non-vaccine therapeutics

Potential use of lipid nanoparticles in non-vaccine therapeutics

Nagy Habib
22 October 2024
Viewpoint
Elevate LNP optimization with Sunshine and Stunner

Elevate LNP optimization with Sunshine and Stunner

Kevin Lance
17 October 2024
Watch
Engineering lipid nanoparticles for lung cancer imaging

Engineering lipid nanoparticles for lung cancer imaging

Ben Knappett, Blaine McCarthy
03 October 2024
Watch
Optimized and scalable LNP composition for RNA vaccine delivery

Optimized and scalable LNP composition for RNA vaccine delivery

Martin Rabel
25 September 2024
Watch
Advancing delivery of RNA therapeutics with cationizable xenopeptides

Advancing delivery of RNA therapeutics with cationizable xenopeptides

Ernst Wagner
24 September 2024
Interview
Addressing the challenge of screening DNA-LNP formulations for targeting the brain

Addressing the challenge of screening DNA-LNP formulations for targeting the brain

Razieh Karamzadeh, Benjamin Knappett
12 September 2024
Watch
Unlocking mRNA-LNP potential using a novel lipid library combined with innovative analytical methods

Unlocking mRNA-LNP potential using a novel lipid library combined with innovative analytical methods

Nejc Pavlin, Guillaume Freund
11 September 2024
Watch
Revolutionizing in vivo genome editing with targeted, non-viral delivery

Revolutionizing in vivo genome editing with targeted, non-viral delivery

Joseph Nabhan, Gary Hao, Qin Yu
11 September 2024
Viewpoint
Delving into the unknowns of mRNA-LNP formulation and characterization

Delving into the unknowns of mRNA-LNP formulation and characterization

Ramesh Marasini
15 July 2024
Interview
Taking a high-throughput approach to enhancing the target specificity and stability of nanoparticles

Taking a high-throughput approach to enhancing the target specificity and stability of nanoparticles

Chun-Wan Yen, Yuchen Fan
20 June 2024
Interview
Simplifying the transition from R&D to GMP-ready LNP production

Simplifying the transition from R&D to GMP-ready LNP production

Benjamin Knappett
16 May 2024
Watch
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
05 April 2024
Viewpoint
The chemistry and biology of oligonucleotide conjugation

The chemistry and biology of oligonucleotide conjugation

Sritama Bose, Peter L Oliver
28 March 2024
Commentary